Dr. Jacob Unger at Maxwell Aesthetics in Nashville, TN, is an investigator enrolling patients for an FDA-reviewed trial exploring Motiva Implants® The U.S. Food and Drug Administration oversees the investigation and approval not only of medicines, but also devices...
4G Clinical, a cutting-edge randomization and trial supply management (RTSM) provider, today announced a strategic partnership with EPS Corporation, one of the largest CROs in Japan. “We are very excited to select 4G Clinical as our IRT/RTSM provider for...
The strategic alliance enables Vivli and TrialScope to promote transparency and data sharing to advance scientific discoveries, reduce redundancies and improve patient care. TrialScope, the global leader in clinical trial transparency, compliance and patient...
Screening Initiated for Phase 1 Pharmacodynamic Effects Trial (Study C-001) Screening Initiated for Second Cohort of Phase 1 Trial in Healthy Adults (Study C-002) Enrollment Completed in Phase 1 Trial in Adults with Acute Otitis Media (Study C-004) New Phase 2a Trial...
Processa Pharmaceuticals, Inc. (OTCQB: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have high unmet medical need conditions, announced today the dosing of the first patient in the...
Email
Text